-

AHF: Bavarian Nordic Must Prioritize Africa in Localized Mpox Vaccine Production

AMSTERDAM--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) today echoed Public Citizen’s call for Denmark-based Bavarian Nordic to take urgent action to ensure equitable access to mpox vaccines by sharing technology and know-how with regional vaccine manufacturers in Africa and lowering the price of its Jynneos vaccine for lower-income countries. AHF also urges wealthy nations with stockpiles of the Jynneos vaccine, particularly those without current mpox outbreaks, to donate doses to the most affected countries immediately.

“While a recent agreement to share vaccine technology with India is a step forward, it falls woefully short of addressing the urgent need for affordable mpox vaccines where they’re needed most,” said AHF Europe Bureau Chief Daniel Reijer. “With Africa still bearing the brunt of the mpox outbreak, Bavarian Nordic must prioritize Africa with lower costs, technology transfer, and regional manufacturing to ensure the most at-risk populations can be protected against mpox – a preventable disease with adequate vaccine access. We cannot continue repeating the inequities of COVID-19, where pharma companies and wealthy nations traded lives for obscenely high profits.”

The Democratic Republic of the Congo, the epicenter of the outbreak, and several neighboring countries have reported more than 50,000 confirmed or suspected cases of mpox and more than 1,000 deaths, with children disproportionately affected. In the DRC, children under 15 account for roughly 60% of the cases and 85% of fatalities.

About AIDS Healthcare Foundation (AHF)

AIDS Healthcare Foundation (AHF) is a global non-profit organization providing cutting-edge medicine and advocacy to more than 2 million people in 48 countries worldwide in Africa, the Americas, the Asia/Pacific Region, and Europe. We are currently the largest non-profit provider of HIV/AIDS medical care in the world. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare

Contacts

US MEDIA CONTACT:
Ged Kenslea, Senior Director, Communications, AHF
+1 323 308 1833 work +1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF
+1 323.308.1829
denys.nazarov@aidshealth.org

AIDS Healthcare Foundation


Release Versions

Contacts

US MEDIA CONTACT:
Ged Kenslea, Senior Director, Communications, AHF
+1 323 308 1833 work +1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF
+1 323.308.1829
denys.nazarov@aidshealth.org

More News From AIDS Healthcare Foundation

Gilead's Earnings Skyrocket as Florida’s AIDS Drug Program Falters, says AHF

LOS ANGELES--(BUSINESS WIRE)--Gilead's Earnings per Share Expected to Be Up 52% as Florida’s and other States’ AIDS Drug Programs Falters, says AHF...

AHF's Gilead Shareholder Resolution Seeks Transparency on Patent Exclusivities

LOS ANGELES--(BUSINESS WIRE)--AHF's Gilead Shareholder Resolution Seeks Transparency on Patent Exclusivities...

AHF Webinar Spotlights Equity as Pandemic Agreement Nears Finish Line

MIAMI--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), in collaboration with the University of Miami Public Health Policy Lab, will cohost a webinar, “Will Equity Prevail? The PABS Annex Negotiations at Their Final Hour,” on Thursday, April 23, 2026 at 10:00 AM EDT, virtually via Zoom. Register here. As WHO Pandemic Agreement negotiations enter a decisive phase ahead of the next Intergovernmental Working Group (IGWG) session, Member States are working to finalize the Pathogen Access and Bene...
Back to Newsroom